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Introduction
“For years, the world of medicine has been steadily advancing the art of robot-assisted
procedures, enabling doctors to enhance their technique inside the operating theatre. Now US
researchers say a robot has successfully performed keyhole surgery on pigs all on its own –
without the guiding hand of a human. Furthermore, they add, the robot surgeon produced
“significantly better” results than humans. The breakthrough is another step towards the day
when fully automated surgery can be performed on patients”.

A CEO of a Dutch public hospital contemplates about what he just read. This is disrupting
news! It will have major consequences when this way of surgery becomes common good. It
requires not only surgeons to rethink their profession but what is more important it requires a
total new vision on healthcare in particular. The speed of development in the healthcare robot
industry is impressive. How much longer does it take before developers find a way to transform
robotic systems from being dependent to semi-autonomous to eventually, fully autonomous
systems, like what he just read?
He also knows about the counter arguments, such as lack of empathy by robots and the fact
that setting up a diagnosis and treating a patient are not linear processes. It requires creativity
and problem-solving skills that algorithms and robots will never (?) have. Besides that, it
requires huge investment requirements.
He however realized that robotization has another price, it forces hospital leaders in particular
to rethink their business models and their purpose. The Dutch word for hospital, ‘ziekenhuis’
house for the ill, might be changed into a house for injured people: just like an automobile
repair center. These people are “only“ injured but not ill. They simply visit the hospital factory
to be repaired. For the injuries automated robots could be a perfect tool. But not only for repair,
through the regrowth of organs, replacement of damaged or diseased organs could also be an
area of opportunity.
On the other hand, the question ‘what is actually meant with the term ill?’ pops up in his mind.
Is a hospital a place of physically injured people only? Some people might have mental
problems as well. Or a complication, a bacterial infection may cause a disease that requires a
cure and sometimes longer hospitalization. Curing is something else than simply repair the
body. Which role plays a robot in that case? What about the people that might need a human
being instead of a robot?
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Healthy high income injured people want to be cured as soon as possible, private clinics
stepped into that market. These clinics have enough investment possibilities. Does that mean
that robotization is for commercial hospitals only? Should a public hospital refrain from this
way of automation and focus more on wellbeing on health care only?
He decides to call some other CEO’s colleagues in the area to have a round table discussion
about this important topic…

Hospital history and concept development
Hospitals from its origin have a religious foundation: Buddhists, Christians and Muslim have
been amongst others religion laying the foundation of what nowadays is called an hospital.

History
“The evolution of the hospital is traced from its onset in ancient Mesopotamia towards the end
of the 2nd millennium to the end of the Middle Ages. Reference is made to institutionalized
health care facilities in India as early as the 5th century BC, and with the spread of Buddhism
to the east, to nursing facilities, the nature and function of which are not known to us, in Sri
Lanka, China and South East Asia. Special attention is paid to the situation in the GraecoRoman era: one would expect to find the origin of the hospital in the modern sense of the word
in Greece, the birthplace of rational medicine in the 4th century BC, but the Hippocratic doctors
paid house-calls, and the temples of Asclepius were visited for incubation sleep and magicoreligious treatment. In Roman times the military and slave hospitals which existed since the
1st century AD, were built for a specialized group and not for the public, and were therefore
also not precursors of the modern hospital. It is to the Christians that one must turn for the
origin of the modern hospital. Hospices, initially built to shelter pilgrims and messengers
between various bishops, were under Christian control developed into hospitals in the modern
sense of the word. In Rome itself, the first hospital was built in the 4th century AD by a wealthy
penitent widow, Fabiola. In the early Middle Ages (6th to 10th century), under the influence of
the Benedictine Order, an infirmary became an established part of every monastery. During
the late Middle Ages (beyond the 10th century) monastic infirmaries continued to expand, but
public hospitals were also opened, financed by city authorities, the church and private sources.
Specialized institutions, like leper houses, also originated at this time. During the Golden Age
of Islam the Muslim world was clearly more advanced than its Christian counterpart with
magnificent hospitals in various countries”.
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Modern Hospital
“A hospital, an institution that is built, staffed, and equipped for the diagnosis of disease; for
the treatment, both medical and surgical, of the sick and the injured; and for their housing
during this process. The modern hospital also often serves as a centre for investigation and
for teaching. To better serve the wide-ranging needs of the community, the modern hospital
has often developed outpatient facilities, as well as emergency, psychiatric, and rehabilitation
services. In addition, “bedless hospitals” provide strictly ambulatory (outpatient) care and day
surgery. Patients arrive at the facility for short appointments. They may also stay for treatment
in surgical or medical units for part of a day or for a full day, after which they are discharged
for follow-up by a primary care health provider. Hospitals have long existed in most countries.
Developing countries, which contain a large proportion of the world’s population, generally do
not have enough hospitals, equipment, and trained staff to handle the volume of persons who
need care. Thus, people in these countries do not always receive the benefits of modern
medicine, public health measures, or hospital care, and they generally have lower life
expectancies”.

Development
Hospitals have developed from an housing facility (Dutch word: ‘Ziekenhuis’ (House for the
Sick)) towards a treatment centre. First diagnosis is done in such a way that treatment is
expected to be successful. One can discover a trend that the ‘housing’ function of the hospital
disappears and focus is more and more concentrated on surgery. Bedless hospitals means
higher ‘turnover’. The modern hospitals transform into a lean and mean operation driven by
the forces of the market (see next paragraph). Curing can be outsourced in order to give the
hospital the possibility to focus on it is core business… The question though is: what is its core
business?

Dutch health care system in transition
In the Netherlands an hospital is considered as secondary care. Since it is expensive one does
not want unnecessary use of the (public) hospital facilities. For that purpose the general
practitioners (primary care) play an important role within the Dutch health care system. They
function as gate keeper. Last but not least the academic hospitals, offering most specialized
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and expensive hospital services is considered as tertiary care, only when secondary care is
not able to come to effective health care solutions.

“Insurers negotiate with providers on price and quality and patients choose the provider they
prefer and join a health insurance policy which best fits their situation. To allow patients to
make these choices, much effort has been made to make information on price and quality
available to the public. The role of the national government has changed from directly steering
the system to safeguarding the proper functioning of the health markets. With the introduction
of market mechanisms in the health care sector and the privatization of former sickness funds,
the Dutch system presents an innovative and unique variant of a social health insurance
system. Since the stepwise realization of the blueprint of the system has not yet been
completed, the health care system in The Netherlands should be characterized as being in
transition”. Many measures have been taken to move from the old to the new system as
smoothly as possible. Financial measures intended to prevent sudden budgetary shocks and
payment mechanisms have been (and are) continuously adjusted and optimized.
Organizational measures aimed at creating room for all players to become accustomed to their
new role in the regulated market. As the system is still a "work in progress", it is too early to
evaluate the effects and the consequences of the new system in terms of accessibility,
affordability, efficiency and quality. Dutch primary care, with gatekeeping GPs at its core, is a
strong foundation of the health care system. This is an attempt to control public spending.
Limited innovation budgets because of lean and mean philosophy and thinking might prevent
successful introductions of robotics in health care.

Gatekeeping GPs are a relatively unusual element in social health insurance systems. The
strong position of primary care is considered to prevent unnecessary use of more expensive
secondary care, and promote consistency and coordination of individual care. It continues to
be a policy priority in The Netherlands. The position of the patient in The Netherlands is
strongly anchored in several laws concerning their rights, their relation to providers and
insurers, access to information, and possibilities to complain in case of maltreatment. In terms
of quality and efficiency of the health care system, The Netherlands is, with some notable
exceptions (e.g. implementation of innovations such as day surgery and electronic patient
records), an average performer when compared to other wealthy countries”.

Rationale behind the Dutch healthcare system
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“The Dutch healthcare system regulates healthcare provision for the population of 17.5 million.
The government’s primary responsibility is creating the conditions for good public health, while
people are personally responsible for their health and wellbeing. The government enables
people to take care of themselves and supports them if they are unable to do so either on their
own or with help from friends and loved ones or other people in their network. The four
objectives underpinning the Dutch healthcare system are good public health, with high-quality
care that is available and affordable to all, both now and in the future. In order to achieve these
objectives, the Netherlands maintains a system of regulated (managed) competition. The
government sets the rules with which new and existing players must comply in order to enter
the healthcare market, there must always be sufficient care available and the care provided
must be regulated. This is how the Dutch government guarantees the quality of public health
in the Netherlands and the quality of the care provided. In order to guarantee solidarity, the
government determines that everyone, by paying taxes, pays their share of curative and longterm care, irrespective of how many people use this care themselves. In order to keep the
increase in healthcare expenses in check, the government enters into what are known as
‘outline agreements’ with the sector; these agreements contain terms on the maximum
increase in healthcare expenses. Within these agreements, the main players determine the
price, quality and service of the care, based on supply and demand; these players are
healthcare purchasers, healthcare providers, and the general public”.

Key players in the Dutch healthcare sector
“Healthcare purchasers, healthcare providers and the public together comprise the three main
players in the Dutch healthcare system: Who fulfils the role of healthcare purchaser depends
on the law in question. The 352 local governments are responsible for this under the Social
Support Act, Youth Act and, to an extent, the Public Health Act. Health insurance providers act
as the purchasing party under the Health Insurance Act. In 2021, the Netherlands is home to
a total of 10 health insurance groups, which includes several health insurers. Under the LongTerm Care Act, there are a total of 31 healthcare administrative offices that act as purchasers.
The main players operate in three ‘markets’:

Healthcare purchasers
The first of these, the health insurance market, applies exclusively to the Health Insurance Act.
Private individuals can decide every year from which health insurance provider they want to
purchase their health insurance. Health insurance providers compete on aspects such as price
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or policy terms. The insured package is the same for the entire population. The other two
markets are relevant to all healthcare laws in the Netherlands.
healthcare providers
In the healthcare procurement market, health insurers, healthcare administrative offices and
local governments decide with which healthcare providers and under what terms and
conditions (within the rules set by the government) they purchase healthcare.
the public
Finally, members of the public operating in the market for health providers decide from which
healthcare provider they would like to receive care. If they choose a provider with which the
healthcare procurement organization has not signed a contract, it sometimes happens that
their care is not, or not fully, covered by their policy”.

The future
In general, Dutch healthcare performs well, but there are major bottlenecks in parts of the
system. To guarantee quality and accessibility, care must be sustainable in terms of financial
means, personnel and public support. However, these three dimensions of sustainability are
under increasing pressure due to developments such as an aging population, the emergence
of new healthcare technology and an increase in the number of chronically ill people.

Robotic surgery
Robotics for Medicine and Healthcare
“Robotics for Medicine and Healthcare is considered the domain of systems able to perform
coordinated mechatronic actions (force or movement exertions) on the basis of processing of
information acquired through sensor technology, with the aim to support the functioning of
impaired individuals, medical interventions, care and rehabilitation of patients and also to
support individuals in prevention programmes.

The field of Robotics for Healthcare is driven by the expectation that robots will be able to play
an important role in helping societies to cope with a number of the big challenges and trends
of the next decades. The application of robotics in healthcare is in many areas a young but
promising field with different segments that are progressing at different speeds. Only a few
The ECASA project (2019-1-DE01-KA203-005037) is financed by Union funds (ERASMUS+). But the
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products have reached the stage of large-scale market introduction, the real measure for
successful innovation. Many applications are still very expensive.
In many instances, it is quite difficult to identify the reasons for discontinued and unsuccessful
projects, since multi-dimensional factors like legal issues, regulations, enabling technologies,
social acceptance and unforeseeable disruptive incidents play key roles.

The first commercial products (ROBODOC, CASPAR, ACROBOT) on the market may serve
as a signal for a greater development to follow, as the potential added value of robots in
healthcare will be fully recognized. The market is expected to grow, as the following examples
indicate. The U.S. market for prosthetics, orthoses and cosmetic enhancement products is
expected to increase from $6.8 billion in 2005 to $10.8 billion in 2010, at an AAGR (average
annual growth rate) of 9.9%. Powered wheelchairs could reach a market volume of a little over
$1 billion by 2013 in the USA and Asia alone. Smart medical capsules may even take over the
whole market for classic colonoscopy screenings as prices for smart medical capsules will drop
below the current $450 per unit. From the side of the stakeholders, e.g. patients, doctors,
hospitals, care institutions, health insurance companies and authorities, it appears that most
of them see the developments as very interesting for the future, but very few of them show an
urgent drive to switch to these new applications right now. Suppliers play a rather supporting
role, but patient involvement in research and development is (too) little. Although government
is not considered a key player in this area, governmental funding for related R&D is crucial”.

Robotics Surgery and limitations
“Robotic surgery continues to diffuse across an increasingly broad range of surgical
procedures. However, concerns have been raised that robotic surgery is more costly and may
be no more effective than other established operative approaches, such as traditional
laparoscopic minimally invasive and open surgery. With respect to costs, for example, robotic
surgery has been associated with episode costs as much as 25% higher compared with
laparoscopic surgery. There are also concerns about the rapid growth of robotic surgery in
areas with limited evidence to support its use and little theoretical benefit or clinical rationale
(eg, inguinal hernia repair). The US Food and Drug Administration (FDA) recently issued a
warning against the use of robotic surgery for the treatment of breast and cervical cancers. In
their communication, they expressed concerns about the lack of epidemiologic data
characterizing the use of robotic surgery in real-world practice settings. Current estimates are
The ECASA project (2019-1-DE01-KA203-005037) is financed by Union funds (ERASMUS+). But the
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limited to single-center studies, device manufacturers’ financial statements, and claims data,
which may be inaccurate owing to unreliable coding”.

Health care robotics and ethical concerns
Replacement and its implications for labour
Are robots introduced to solve problems in healthcare and elderly care, or are they introduced
to save money by replacing human care givers by robots, and to help robotics research and
industry? For instance, in research concerning the development of robots for the elderly, robots
are often presented as a response to demographic challenges. But are such technological
solutions the main or only way we should tackle these challenges? And if there is truth in the
suspicion that robots will replace humans, which problems exactly would they solve, and is
robotics really a threat to employment? More generally, what are the consequences for
healthcare work? For example, do robots and ICTs threaten ‘‘care craftsmanship’’?

De-humanisation and ‘‘cold’’ care
An important fear in discussions about robots in healthcare is that robots may replace human
care givers, and that this may not only put these people out of job, but also remove the capacity
for ‘‘warm’’, ‘‘human’’ care from the care process. It is highly doubtful, for instance, if robots
could ever be empathic or have emotions. Robots, it seems, are not capable of a ‘‘human’’
kind of attention and care, whereas healthcare seems to involve more than some ‘‘behaviours’’;
humans have various social and emotional needs, which are not necessarily met by giving
them a robot. ‘‘Machine care’’ sounds cold and mechanical. There is the concern that elderly
people are abandoned, handed over to robots devoid of human contact. Cold care might be
good in the operation room but cold care for patients with Alzheimer disease could be
disastrous. More generally, do machines in care ‘‘objectify’’ care receivers? Do they objectify
care givers (see also the previous point)? What do we mean by good healthcare? Do we have
good healthcare today, without even considering robots? Is good care possible in the context
of modernity?

Autonomy.
Not all health care robots are autonomous robots. For instance, surgical robots are remote
controlled by the surgeon. Yet health care research often aims to give more autonomy to the
The ECASA project (2019-1-DE01-KA203-005037) is financed by Union funds (ERASMUS+). But the
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robot. An important term in the field, for instance, is autonomous systems. Autonomy means
here that the robot is designed to carry out tasks without continuous human guidance and
assistance, preferably in an unstructured environment. This development could lead to a future
scenario in which robots would replace human care workers, for instance if care robots take
over the work of the human nurse. As indicated before, this is ethically problematic. But even
if robots in healthcare did not entirely replace human care workers, there is still the question
how autonomous (in the sense of doing tasks on its own, unassisted by humans) the robot
would be and should be in the context of the interaction and the care, and how autonomous it
should be in the sense of operating without human supervision. For example, if robots are used
in therapy for children, should the robot be supervised (and if so in what way) and what exactly
and how much should it do without direct human intervention?

Role and tasks
Related to the previous point is the question regarding the role of the robot in the particular
care process. Even if humans are still part of the care process, what exactly should the role of
the robot be (and the role of the human)? What tasks can and should be delegated to robots?
And in general: should they assist or take over human tasks? When and where should they do
what?

Moral agency
Robots do not seem to have the capacity of moral reasoning or, more generally, of dealing
with ethically problematic situations. Hence when a moral problem arises within the human–
robot interaction and within the healthcare situation, there seems to be a problem: the robot is
given (more) autonomy, in the sense of doing tasks by itself without human intervention, but
does not seem to have the capacity of moral agency: it can do all kinds of things, but unlike
humans does not have the capacity to reflect on the ethical quality of what it does. Some
philosophers therefore propose to build-in a capacity for ethical reasoning, whereas other
philosophers deny that this is possible or think it is insufficient for dealing with complex ethical
issues in healthcare. On the other hand, maybe the robot’s lack of moral agency is not a
problem as long as humans are involved and included in the process. Again the issues of
autonomy and role are raised.
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Responsibility
This issue raises again the question regarding the autonomy and role of the robot and the
human and, more generally, regarding human–technology relations. How does the introduction
of robots (re-)shape ethical responsibilities? If the robot takes over human tasks, who is
responsible for these tasks? What should be the new distribution of responsibility, when robots
take over some tasks? Does it mean that humans remain responsible (assuming the robots
cannot be morally responsible), and if so, how can they exercise this responsibility if they have
not direct control over the robot (if they do not continuously intervene) or even do not supervise
the robot?

Deception
If robots are used as ‘‘social’’ companions and are given other roles which encourage social–
emotional involvement of the humans (e.g. elderly people or children), is this not a case of
deception, and if so, is this deception justifiable?

Trust
In so far as the robot acts autonomously and human care givers withdraw from the care
process (to some extent at least), can the robot be ‘‘trusted’’, or is this term not applicable to
robots? Should we only talk about reliability? Or do ‘‘social’’ robots raise the issue of trust?
Shall we ‘‘trust’’ giving patients, elderly people, and children ‘‘in the hands of the robot’’?

Privacy and data protection:
Robotics research and use of robots in healthcare raise questions about which data are
collected, how they are stored, who has access to them, who owns them, what happens to
them, and so on.

Safety and avoidance of harm.
Robots should not harm people and be safe to work with. This point is especially important in
healthcare and related domains, since it often involves vulnerable people such as ill people,
elderly people, and children”.
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Epiloque
The CEO’s thinking has developed. The topics for the round table are clear now. According to
him, the discussion should follow the following steps that should functions as a filter. And it
should not be a freely brainstorming event. It should result in a clear business case.

(S) Suitability
First of all the roundtable participant should discuss the suitability of robotic systems within
their hospital environment. Which application really solves a problem. It might save time as the
robot is faster, the robot produces better quality, is less dependent, is more flexible, more
sustainable and is cheaper..

(A) Acceptability
If an application area and its robotic use is suitable the question remains whether is it
acceptable. The likely return of investment? Discussions about the opinions and reactions of
the various involved stakeholders. Discussions and decisions about the level of risk should
also take place. Last but not least the concerns about the ethics involved should also be
covered. Although some might be discussed during the suitability session from a functional
perspective. A robot could give elderly accompany but what is the objective behind the
application: is it a timesaving argument or is the robot simply better in “loving”?

(F) Feasibility
Last but not least the economy of the application should be discussed. The business case.
Does is work in practice, can the strategy be financed, do people with the required skills exist,
can they be trained, can other required resources be obtained and integrated in the process
of the operating system?

The CEO realizes that this is not just a simple discussion. In order to make this work, he
decides to make the discussion more practical and focus on just one case: prepless colon
capsule technology. He will produce a document what will serve on the one hand as
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information’s package and on the other hand as an agenda for the roundtable discussion
following the SAF scheme… a lot of work!

He starts to read “Colorectal Cancer and Polyp Detection Using a New Preparation-Free,
Colon-Scan Capsule: A Pilot Study of Safety and Patient Satisfaction” an important source to
start off…
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